NHS Finance

08.06.18

DH ‘can’t fully explain’ why NHS spent 7 times more money on generic meds last year

Prices of generic medicines purchased by CCGs for primary care have soared sevenfold in the past year alone, yet the Department of Health and Social Care (DHSC) “could not fully explain” the cause of the surge, a new report has found.

Findings from the National Audit Office (NAO) revealed that an increase in selling prices of generic medicine from wholesalers and manufacturers to CCGs has amounted to an additional £315m in costs to the NHS in the last year alone.

Unlike new, patent-protected medicines, pharmacies buy generic medicines from wholesalers who can set their own prices (the DHSC do not set prices on generic medicines). If pharmacies cannot get a medicine at a set price from a wholesaler, they can ask the government to use a mechanism called concessionary prices, which means the government can set a temporary higher reimbursement price for pharmacies.

But in the last year, the wholesale price of generic medicines skyrocketed: total costs for the NHS were seven times greater than the equivalent spend in 2016-17. The costs of some medicines increased by more than 10 times their price the year before. For example, the wholesaler price for quetiapine 100mg tablets was £113.10 last year, 70 times higher than its previous price of £1.59.

The surge in prices set by wholesalers meant there was an “unprecedented” rise in the number of requests from pharmacies for concessionary prices: an increase from fewer than 150 a month before May 2017 to a peak of 3,000 in November that year. In 2016-17, the NHS spent an estimated £4.3bn on generic medicines, which was mostly (£3.5bn) spent on primary care.

The DHSC believe the price increases are related to the suspension of some manufacturers’ licenses and the fall in the value of the sterling, but the NAO claims that the department “cannot fully verify or quantify” these suspicions.

Wholesalers’ margins were also identified as an unexpected increase in the market, the report said: “The department identified increases in manufacturers’ prices, but also unexpected increases in wholesalers’ margins in 2017, which it could not fully explain. The NHS will not be able to get back the expenditure due to the increase in manufacturer and wholesaler prices.”

Meg Hillier, chair of the Public Accounts Committee, said: “The exponential increase in generic drug costs, in some cases tenfold, means money that could have been spent on local healthcare has instead been eaten up in an inflated drugs budget. NHS England needs to make sure this does not happen again.”

Medicines can be ‘branded’ or ‘generic.’ New medicines have patents that are protected for a minimum of 20 years under their brand name, intended to allow pharmaceutical companies to fully conduct and test their research.

Enjoying NHE? Subscribe here to receive our weekly news updates or click here to receive a copy of the magazine!

Comments

There are no comments. Why not be the first?

Add your comment

 

national health executive tv

more videos >

latest healthcare news

‘Damaging’ NHS targets ‘have had their day’ claims Lord Prior

15/02/2019‘Damaging’ NHS targets ‘have had their day’ claims Lord Prior

NHS targets “have had their day” according to Lord Prior as the head of the health service launches an attack on 25 years of flawed h... more >
Controversial shake-up of Kent stroke services given rubber stamp amid calls for judicial review

15/02/2019Controversial shake-up of Kent stroke services given rubber stamp amid calls for judicial review

A major reorganisation of stroke services across Kent and Medway have been approved following a unanimous decision by the Joint Committee of CCGs... more >
A&E waiting time performance hits all time low as NHS ‘buckles under the strain’

15/02/2019A&E waiting time performance hits all time low as NHS ‘buckles under the strain’

A&E waiting time performances in NHS trusts in England have hit their lowest level since regards began, according to the latest NHS statistic... more >

editor's comment

25/09/2017A hotbed of innovation

This edition of NHE comes hot on the heels of this year’s NHS Expo which, once again, proved to be a huge success at Manchester Central. A number of announcements were made during the event, with the health secretary naming the second wave of NHS digital pioneers, or ‘fast followers’, which follow the initial global digital exemplars who were revealed at the same show 12 months earlier.  Jeremy Hunt also stated th... read more >

last word

Hard to be optimistic

Hard to be optimistic

Rachel Power, chief executive of the Patients Association, warns that we must be realistic about the very real effects of continued underfunding across the health service. It’s now bey... more > more last word articles >

the scalpel's daily blog

Blog: 5 minutes with Dr Tracy Vell MBE, Associate Lead for Primary and Community Care, Greater Manchester, Health and Social Care Partnership.

14/02/2019Blog: 5 minutes with Dr Tracy Vell MBE, Associate Lead for Primary and Community Care, Greater Manchester, Health and Social Care Partnership.

Ahead EvoNorth we caught up with Dr Tracy Vell MBE, Associate Lead for Primary and Community Care, Greater Manchester, Health and Social Care Partnership. Dr Tracy Vell MBE shares her thoughts on the Northern Powerhouse, what it means to her and why she thinks it’s important to attend EvoNorth.  What does your role as ... more >
read more blog posts from 'the scalpel' >

comment

Maximising volunteer potential in hospitals

14/02/2019Maximising volunteer potential in hospitals

Sam Ward, director of commissioned services at the Royal Voluntary Service, argues that the right training can help harness the power of voluntee... more >
Leading and managing experts

14/02/2019Leading and managing experts

A coaching conversation is likely to yield the best results. Managing experts in the health industry can be a challenging and varying responsibil... more >
Mesothelioma in the UK: a growing fight

14/02/2019Mesothelioma in the UK: a growing fight

The health impacts of asbestos in the UK can cast a much wider net than those in the construction and building sector. Liz Darlison, head of serv... more >
ICO: Cyber security and the NHS

14/02/2019ICO: Cyber security and the NHS

Peter Brown, acting head of technology policy at the Information Commissioner's Office (ICO), explains the importance of good practice in data pr... more >

interviews

How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

24/10/2018How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

A dedicated national social care service could be a potential solution to surging demand burdening acute health providers over the winter months,... more >
RCP president on new Liverpool college building: ‘This will be a hub for clinicians in the north’

24/10/2018RCP president on new Liverpool college building: ‘This will be a hub for clinicians in the north’

The president of the Royal College of Physicians (RCP) has told NHE that the college’s new headquarters based in Liverpool will become a hu... more >
Duncan Selbie: A step on the journey to population health

24/01/2018Duncan Selbie: A step on the journey to population health

The NHS plays a part in the country’s wellness – but it’s far from being all that matters. Duncan Selbie, chief executive of Pu... more >
Cutting through the fake news

22/11/2017Cutting through the fake news

In an era of so-called ‘fake news’ growing alongside a renewed focus on reducing stigma around mental health, Paul Farmer, chief exec... more >

health service focus

View all News